Señales en vivo de NUWE | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 abr 2024 @ 16:00):

Stats
Volumen de hoy	18.26M
Volumen promedio	1.27M
Capitalización de mercado	1.14M
EPS	US12542Q700 ( 2024-03-05 )
Próxima fecha de ganancias	( US12542Q70-0.930 ) 2024-05-14
Last Dividend	US12542Q700 ( N/A )
Next Dividend	US12542Q700 ( N/A )
P/E	-0.0100
ATR14	US12542Q700.00100 (0.59%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-02	Mccormick Michael Kendrick	Buy	20 836	Nonstatutory Stock Option (right to buy)
2024-01-02	Mcdonald David	Buy	11 365	Nonstatutory Stock Option (right to buy)
2024-01-02	Feldshon Archelle Georgiou	Buy	11 365	Nonstatutory Stock Option (right to buy)
2023-11-01	Mcdonald David	Buy	0
2023-11-01	Feldshon Archelle Georgiou	Buy	0

INSIDER POWER
97.91
Last 90 transactions
Buy: 3 285 386 \| Sell: 12 287

Volumen Correlación

Largo: -0.21 (neutral)

Corto: -0.23 (neutral)

Signal:(56.294) Neutral

Nuwellis, Inc. Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Nuwellis, Inc. Correlación - Moneda/Commodity

0.00
( neutral )

0.03
( neutral )

Nuwellis, Inc. Finanzas

Annual	2023
Ingresos:	US12542Q708.86M
Beneficio Bruto:	US12542Q704.98M (56.22 %)
EPS:	US12542Q70-10.29

FY	2023
Ingresos:	US12542Q708.86M
Beneficio Bruto:	US12542Q704.98M (56.22 %)
EPS:	US12542Q70-10.29

FY	2022
Ingresos:	US12542Q708.54M
Beneficio Bruto:	US12542Q704.76M (55.66 %)
EPS:	US12542Q70-83.48

FY	2021
Ingresos:	US12542Q707.92M
Beneficio Bruto:	US12542Q704.49M (56.70 %)
EPS:	US12542Q70-285.73

Financial Reports:

No articles found.

Nuwellis, Inc.

Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.